key point someone made Dendreonhad phase 3 results from Provenge 22.5% CR.
I'm just dissapointed with the release.
Any other company would have done it reverse. They would have titled the PR. ENDO/BNC release positive phase 3 results for Urocidin and details of results with be release at upcoming conference in May.